http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-2018002545-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae10212794160b34478f0d05b6ab6fd7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate 2018-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be6e63ab534b010cbeb5b34256e0f258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b700063eef1b7f3e9fe40e3f6cc07f7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcb7963f750a30298207220288a494c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd03ed510f18abb11108d697ec64ef8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_069df3d9e3c5805027af3b8a0655fd23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22db60c0fbfde0ff0438900c5e8a3a9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4794fde459d7376add0d7423016a89a
publicationDate 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-2018002545-A2
titleOfInvention Formulations of 3- (5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl) -piperidin-2,6-dione
abstract Pharmaceutical compositions and unit dosage forms of Compound A (3- (5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl) -piperidin-2,6-dione) are provided herein, or an enantiomer or a mixture of enantiomers thereof, a solvate, hydrate, co-crystal, clathrate, polymorph or pharmaceutically acceptable salt thereof. Methods are also provided to treat, control or prevent cancer with the dosage forms described herein.
priorityDate 2015-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421809005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24967599

Total number of triples: 27.